Lv11
30 积分 2024-09-19 加入
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
10小时前
待确认
Chronic kidney disease
5天前
已完结
Chronic Kidney Disease
5天前
已完结
Management of obesity in menopause
14天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
1个月前
已完结
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
1个月前
已完结
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
1个月前
已完结
Az Expanded Disability Status Scale használata és a motoros képességek vizsgálata sclerosis multiplexes betegekben
1个月前
已关闭
皖公网安备34019202002308
